Controlled release oral pharmaceutical dosage forms comprising MGBG
US10881626B2 · kind B2 · utility
0Cited by
26References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2017 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | May 1, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C251/78
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.